Prophylactic chemotherapy of patients with molar pregnancy.
D000032:Abortion, Therapeutic; D000328:Adult; D001219:Aspartate Aminotransferases / Q000097:blood; D001772:Blood Cell Count; D002822:Choriocarcinoma / Q000517:prevention & control; D006063:Chorionic Gonadotropin / Q000097:blood / Q000652:urine; D003475:Curettage; D003609:Dactinomycin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005865:Gestational Age; D006801:Humans; D006828:Hydatidiform Mole / Q000188:drug therapy*; D007044:Hysterectomy; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D014328:Trophoblastic Neoplasms / Q000517:prevention & control
D006063:Chorionic Gonadotropin; D003609:Dactinomycin; D001219:Aspartate Aminotransferases; D008727:Methotrexate